Science & News
At Lo.Li. Pharma International, every step forward tells a story.
We believe that progress gains meaning when it’s shared, that’s why we open the door to the moments, insights, and milestones that build our journey.
From scientific advances to global events, from partnerships to everyday collaboration, this is where our path takes shape.
Science
GDM and Myo-inositol: state of art
Gestational diabetes mellitus (GDM) is a metabolic disorder characterised by an impaired glucose tolerance with onset or first recognition during pregnancy, which is characterized by
Ulipristal acetate in the treatment of Uterine Fibroids: EMA restrictions of use.
Uterine Fibroids and Ulipristal Acetate Uterine fibroids are benign tumours consisting of smooth muscle cells and connective tissues that grow within the uterine wall and
Quality of women’s life and polycystic ovary syndrome (PCOS)
Polycystic ovary syndrome (PCOS) is characterised by enlarged ovaries, multiple ovarian cysts and endocrinological and metabolic changes (hyperandrogenism, insulin resistance and consequent hyperinsulinemia). Among women
News
Ops…we did it again!
From October 28th to 30th, 2025, Lo.Li. Pharma International proudly took part in CPHI Frankfurt, the world’s leading event for the pharmaceutical and life sciences
15th Croatian Congress on gynecological endocrinology, human reproduction and menopause
On September 11–12, we had the opportunity to attend the 𝟭𝟱𝘁𝗵 𝗖𝗿𝗼𝗮𝘁𝗶𝗮𝗻 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝗼𝗻 𝗚𝗬𝗡𝗘𝗖𝗢𝗟𝗢𝗚𝗜𝗖𝗔𝗟 𝗘𝗡𝗗𝗢𝗖𝗥𝗜𝗡𝗢𝗟𝗢𝗚𝗬, 𝗛𝗨𝗠𝗔𝗡 𝗥𝗘𝗣𝗥𝗢𝗗𝗨𝗖𝗧𝗜𝗢𝗡 𝗔𝗡𝗗 𝗠𝗘𝗡𝗢𝗣𝗔𝗨𝗦𝗘 in Opatija. We truly enjoyed
VITAFOODS 2025
A heartfelt thank you to everyone who visited our booth at Vitafoods Europe in Barcelona!It was a pleasure to showcase our latest developments and connect